Data from Caspase-3–Induced Activation of SREBP2 Drives Drug Resistance via Promotion of Cholesterol Biosynthesis in Hepatocellular Carcinoma
Etienne Ho Kit Mok(University of British Columbia), Terence K. Lee(Hong Kong Polytechnic University), Hoi-Wing Leung(Chinese University of Hong Kong), D. M. H. Baker(Smithsonian Tropical Research Institute), Martina Mang Leng Lei(Hong Kong Polytechnic University), Stephanie Ma(University of Hong Kong - Shenzhen Hospital), Jonathan D. Cybulski(University of Hong Kong), Dan Lindholm(Linköping University), Irene Oi‐Lin Ng(University of Hong Kong), Jing‐Ping Yun(Ministry of Agriculture and Rural Affairs), Eunice Y. Lau(Queen Elizabeth Hospital), Man Tong(Chinese University of Hong Kong), Lei Zhou(Tongji University), Jun Yu(Yueyang Second People's Hospital), Hui Zhu, Jin Ding(Chinese Academy of Sciences), Kin Sum Leung(Norwegian Womens Public Health Association), Carmen Oi Ning Leung(Hong Kong Polytechnic University), Chi Ho Lin(Education University of Hong Kong), Tin Lok Wong(University of Hong Kong)
Cited by 0
Related Papers
A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening
|Cell stem cell|2018|723
Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
|Nature Reviews Gastroenterology & Hepatology|2021|472
Understanding the gut microbiota and sarcopenia: a systematic review
|Journal of Cachexia Sarcopenia and Muscle|2021|340
Single-cell RNA sequencing shows the immunosuppressive landscape and tumor heterogeneity of HBV-associated hepatocellular carcinoma
|Nature Communications|2021|333
Hallmarks of cancer stemness
|Cell stem cell|2024|251